18234742. STREPTOCOCCAL GlcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
Contents
- 1 STREPTOCOCCAL GlcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM
- 1.1 Organization Name
- 1.2 Inventor(s)
- 1.3 STREPTOCOCCAL GlcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM - A simplified explanation of the abstract
- 1.4 Simplified Explanation
- 1.5 Potential Applications
- 1.6 Problems Solved
- 1.7 Benefits
- 1.8 Original Abstract Submitted
STREPTOCOCCAL GlcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM
Organization Name
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Inventor(s)
Victor Nizet of San Diego CA (US)
Nina Van Sorge of Leusden (NL)
STREPTOCOCCAL GlcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM - A simplified explanation of the abstract
This abstract first appeared for US patent application 18234742 titled 'STREPTOCOCCAL GlcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM
Simplified Explanation
The patent application describes vaccines, pharmaceutical compounds, and formulations for diagnosing, preventing, treating, or improving Group A (GAS), Group C (GCS), or Group A (GGS) infections, or other pathogenic infections. It also includes compositions such as diagnostic tests, assays, immunoassays, and test strips, as well as methods for detecting or diagnosing the presence of a Streptococcal infection or other pathogenic infections.
- Vaccines, pharmaceutical compounds, and formulations for Group A (GAS), Group C (GCS), or Group A (GGS) infections
- Compositions for diagnostic tests, assays, immunoassays, and test strips
- Methods for detecting or diagnosing Streptococcal infections or other pathogenic infections
Potential Applications
- Medical industry: The invention can be used in the development of vaccines and pharmaceutical compounds for diagnosing, preventing, treating, or ameliorating Group A (GAS), Group C (GCS), or Group A (GGS) infections, or other pathogenic infections.
- Diagnostic industry: The invention provides compositions and methods for detecting or diagnosing the presence of Streptococcal infections or other pathogenic infections, which can be used in diagnostic tests, assays, immunoassays, and test strips.
Problems Solved
- Lack of effective vaccines and pharmaceutical compounds for Group A (GAS), Group C (GCS), or Group A (GGS) infections, or other pathogenic infections.
- Limited options for detecting or diagnosing Streptococcal infections or other pathogenic infections.
Benefits
- Improved ability to diagnose, prevent, treat, or ameliorate Group A (GAS), Group C (GCS), or Group A (GGS) infections, or other pathogenic infections.
- Enhanced accuracy and efficiency in detecting or diagnosing the presence of Streptococcal infections or other pathogenic infections.
Original Abstract Submitted
In alternative embodiments, the invention provides vaccines, pharmaceutical compounds and formulations for diagnosing, preventing, treating or ameliorating Group A (GAS), Group C (GCS), or Group A (GGS), infections, or other pathogenic infections. In alternative embodiments, the invention provides compositions such as diagnostic tests, assays, immunoassays and test strips, and methods, for detecting or diagnosing the presence of a Streptococcal infection, e.g., Group A (GAS), Group C (GCS), or Group A (GGS), infections, or other pathogenic infections.
